Aura Bios appointed Jeremy Bender, Ph.D., M.B.A., as a Class II director effective July 7, 2026, and named him to the Compensation Committee and the Nominating and Corporate Governance Committee.

IndividualJeremy Bender, Ph.D., M.B.A.RoleClass II Director; member, Compensation Committee; member, Nominating and Corporate Governance CommitteeType of ChangeAppointedEffective DateJuly 7, 2026ReasonTo fill newly created vacancy after Board increased size from six to seven directorsReplacement InfoNot disclosedBackground DetailsQualified as independent director; term expires at 2029 annual meeting; will enter indemnification agreement; eligible for non-employee director cash compensation and initial equity awards (60,000 option shares; 30,000 RSUs) vesting over three yearsBoard/Committee Role ChangesAppointed to Compensation Committee and Nominating and Corporate Governance Committee

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.